# Clinical Trial With MSC for Graft Versus Host Disease Treatment

> **NCT02687646** · PHASE1,PHASE2 · COMPLETED · sponsor: **Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud** · enrollment: 16 (actual)

## Conditions studied

- Acute Graft Versus Host Disease

## Interventions

- **DRUG:** Adult Allogeneic Mesenchymal cells from adipose tissue.

## Key facts

- **NCT ID:** NCT02687646
- **Lead sponsor:** Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-20
- **Primary completion:** 2022-01-21
- **Final completion:** 2022-01-21
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687646, "Clinical Trial With MSC for Graft Versus Host Disease Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02687646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*